Therapy of spinal muscular atrophy using suberoylanilide hydroxamic acid, a second generation histone deacetylase inhibitor

被引：0
|
作者：
Hahnen, E [1 ]
Eyüpoglu, IY [1 ]
Brichta, L [1 ]
Haastert, K [1 ]
Tränkle, C [1 ]
Siebzehnrübl, FA [1 ]
Riessland, M [1 ]
Hölker, I [1 ]
Claus, P [1 ]
Romstöck, J [1 ]
Buslei, R [1 ]
Wirth, B [1 ]
Blüumcke, I [1 ]
机构：
[1] Univ Cologne, Inst Humangenet, D-50931 Cologne, Germany
来源：
ACTA NEUROPATHOLOGICA | 2005年 / 110卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：326 / 326
页数：1
相关论文
共 50 条
  • [1] Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, in relapsed leukemias
    不详
    CLINICAL LYMPHOMA, 2004, 5 (02): : 78 - 79
  • [2] The Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid Alleviates Salinity Stress in Cassava
    Patanun, Onsaya
    Ueda, Minoru
    Itouga, Misao
    Kato, Yukari
    Utsumi, Yoshinori
    Matsui, Akihiro
    Tanaka, Maho
    Utsumi, Chikako
    Sakakibara, Hitoshi
    Yoshida, Minoru
    Narangajavana, Jarunya
    Seki, Motoaki
    FRONTIERS IN PLANT SCIENCE, 2017, 7
  • [3] The histone deacetylase inhibitor Suberoylanilide Hydroxamic Acid (SAHA) as a therapeutic agent in rhabdomyosarcoma
    Ghayad, Sandra E.
    Rammal, Ghina
    Sarkis, Omar
    Basma, Hussein
    Ghamloush, Farah
    Fahs, Assil
    Karam, Mia
    Harajli, Mohamad
    Rabeh, Wissam
    Mouawad, Joe E.
    Zalzali, Hassan
    Saab, Raya
    CANCER BIOLOGY & THERAPY, 2019, 20 (03) : 272 - 283
  • [4] In vitro and in vivo histone deacetylase inhibitor therapy with suberoylanilide hydroxamic acid (SAHA) and paclitaxel in ovarian cancer
    Cooper, Amy L.
    Greenberg, Victoria L.
    Lancaster, Pamela S.
    van Nagell, John R., Jr.
    Zimmer, Stephen G.
    Modesitt, Susan C.
    GYNECOLOGIC ONCOLOGY, 2007, 104 (03) : 596 - 601
  • [5] Inhibition of oral carcinogenesis in rats by the histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA)
    McCormick, David L.
    Horn, Thomas L.
    Johnson, William D.
    Lubet, Ronald A.
    Steele, Vernon E.
    CANCER RESEARCH, 2011, 71
  • [6] The Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid (SAHA) Induces Differentiation of Intestinal Cells
    Roostaee, Alireza
    Benoit, Yannick D.
    Guezguez, Amel
    Simoneau, Aline
    Beaulieu, Jean-Francois
    GASTROENTEROLOGY, 2014, 146 (05) : S785 - S785
  • [7] The mechanism of Histone deacetylase inhibitor (Suberoylanilide hydroxamic acid) suppresses pancreatic cancer in vitro
    Yang, Bo
    Li, Shengze
    Zhou, Quansheng
    Cao, Cong
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 34 : S44 - S44
  • [8] Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, improved radiosensitivity of human hepatocellular carcinoma
    Chen, Fang-Hsin
    Yu, Ching-Fang
    Hong, Ji-Hong
    CANCER RESEARCH, 2017, 77
  • [9] The histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces cardiac arrhythmias in dystrophic mice
    Colussi, Claudia
    Berni, Roberta
    Rosati, Jessica
    Straino, Stefania
    Vitale, Serena
    Spallotta, Francesco
    Baruffi, Silvana
    Bocchi, Leonardo
    Delucchi, Francesca
    Rossi, Stefano
    Savi, Monia
    Rotili, Dante
    Quaini, Federico
    Macchi, Emilio
    Stilli, Donatella
    Musso, Ezio
    Mai, Antonello
    Gaetano, Carlo
    Capogrossi, Maurizio C.
    CARDIOVASCULAR RESEARCH, 2010, 87 (01) : 73 - 82
  • [10] Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, attenuates postoperative cognitive dysfunction in aging mice
    Jia, Min
    Liu, Wen-Xue
    Sun, He-Liang
    Chang, Yan-Qing
    Yang, Jiao-Jiao
    Ji, Mu-Huo
    Yang, Jian-Jun
    Feng, Chen-Zhuo
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2015, 8
12345